Determinants of increased energy expenditure in HIV-infected women

American Journal of Clinical Nutrition

Volumn 68, Issue 3, 1998, Pages 720-725

  Grinspoon, Steven ^a   Corcoran, Colleen ^a   Miller, Karen ^a   Wang, Emily ^a   Hubbard, Jane ^a   Schoenfeld, David ^a   Anderson, Ellen ^a   Basgoz, Nesli ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Energy expenditure; Fat free mass; HIV; Human immunodeficiency virus; Leptin; Resting energy expenditure; Weight; Women

Indexed keywords

ESTRADIOL; LEPTIN; SOMATOMEDIN C; TESTOSTERONE;

ARTICLE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE FUNCTION TEST; IMPEDANCE; NUTRITIONAL STATUS; SKINFOLD THICKNESS; WASTING SYNDROME;

EID: 0031719465     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.3.720     Document Type: Article

References (24)

1. Hommes MJ, Romijn JA, Godfried MH, et al. Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism 1990;39:1186-90.
2. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992; 55:455-60.
3. Melchior JC, Salmon D, Rigaud D, et al. Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr 1991;53:437-41.
4. Mulligan K, Tai VW, Schambelan M. Energy expenditure in human immunodeficiency virus infection. N Engl J Med 1997;336:70-1 (letter).
5. Macallan DE, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995;333:83-8.
6. Grinspoon S, Corcoran C, Miller K, et al. Body composition and endocrine function in women with AIDS wasting. J Clin Endocrinol Metab 1997;82:1332-7.
7. Centers for Disease Control and Prevention. Revision of the CDC surveillance definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36:3S-15S.
8. Harris JA, Benedict FG. A biometric study of basal metabolism in man. Washington, DC: Carnegie Institute of Washington, 1919.
9. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990;51:1106-12.
10. Jordan CD, Flood JG, Laposata M, Lewandrowski KB. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N Engl J Med 1992;327:718-24.
11. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Analysis of human plasma leptin by radioimmunoassay. Clin Chem 1996;42:942-6.
12. Ravussin E, Bogardus C. Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr 1989;49(suppl):968-75.
13. Astrup A, Thorbek G, Lind J, Isaksson B. Prediction of 24-h energy expenditure and its components from physical characteristics and body composition in normal-weight humans. Am J Clin Nutr 1990;52:777-83.
14. Cunningham JJ. A reanalysis of the factors influencing basal metabolic rate in normal adults. Am J Clin Nutr 1980;33:2372-4.
15. Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24-hour energy expenditure in man. J Clin Invest 1986;78:1568-78.
16. Astrup A, Buemann B, Christiansen NJ, et al. The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women. J Clin Endocrinol Metab 1992;74:279-86.
17. Lovejoy J, Bray G, Bourgeois MO, et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - a clinical research center study. J Clin Endocrinol Metab 1996;81:2198-203.
18. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
19. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nat Med 1995;1:1155-61.
20. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-2.
21. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
22. Yarasheski KE, Zachwieja JZ, Horgan MM, Powderly WG, Santiago JV, Landt M. Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. Metabolism 1997;46:303-5.
23. Grunfeld C, Pang M, Shigengaga JK, et al. Serum leptin levels in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1996;81:4342-6.
24. Nagy TR, Gower BA, Shewchuk RM, Goran MI. Serum leptin and energy expenditure in children. J Clin Endocrinol Metab 1997; 82:4149-53.